In brief
Novo Nordisk rolled out an oral version of Wegovy in the U.S., marking the first pill-based GLP-1 approved specifically for weight loss.
GLP-1 drugs from Novo Nordisk and Eli Lilly have surged in popularity, though injections, side effects, and cost have remained barriers for some p